Back to Search Start Over

Fast killing kinetics, significant therapeutic index, and high stability of melittin-derived antimicrobial peptide.

Authors :
Akbari, Reza
Hakemi Vala, Mojdeh
Sabatier, Jean-Marc
Pooshang Bagheri, Kamran
Source :
Amino Acids. Sep2022, Vol. 54 Issue 9, p1275-1285. 11p.
Publication Year :
2022

Abstract

The emergence of multidrug-resistant (MDR) bacteria is a major challenge for antimicrobial chemotherapy. Concerning this issue, antimicrobial peptides (AMPs) have been presented as novel promising antibiotics. Our previous de novo designed melittin-derived peptides (MDP1 and MDP2) indicated their potential as peptide drug leads. Accordingly, this study was aimed to evaluate the kinetics of activity, toxicity, and stability of MDP1 and MDP2 as well as determination of their structures. The killing kinetics of MDP1 and MDP2 demonstrate that all bacterial strains were rapidly killed. MDP1 and MDP2 were ca. 100- and 26.6-fold less hemolytic than melittin and found to be respectively 72.9- and 41.6-fold less cytotoxic than melittin on the HEK293 cell line. MDP1 and MDP2 showed 252- and 132-fold improvement in their therapeutic index in comparison to melittin. MDP1 and MDP2 sustained their activities in the presence of human plasma and were found to be ca. four to eightfold more stable than melittin. Spectropolarimetry analysis of MDP1 and MDP2 indicates that the peptides adopt an alpha-helical structure predominantly. According to the fast killing kinetics, significant therapeutic index, and high stability of MDP1, it could be considered as a drug lead in a mouse model of septicemia infections. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
09394451
Volume :
54
Issue :
9
Database :
Academic Search Index
Journal :
Amino Acids
Publication Type :
Academic Journal
Accession number :
158485212
Full Text :
https://doi.org/10.1007/s00726-022-03180-2